IL6 and COVID-19: Elevated levels of pro-inflammatory cytokines, interleukin-1 (IL1β), interleukin-6 (IL6), and tumor necrosis factor-α (TNFα) in moderate to severe COVID-19 cases contribute to the hyperinflammatory response (Maiti et al., 2020; Tang et al., 2020).